Previous Close | 0.0050 |
Open | 0.0050 |
Bid | 0.0050 x N/A |
Ask | 0.0100 x N/A |
Day's Range | 0.0050 - 0.0050 |
52 Week Range | 0.0050 - 0.0750 |
Volume | |
Avg. Volume | 244,144 |
Market Cap | 2.304M |
Beta (5Y Monthly) | 1.16 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1270 |
Earnings Date | Feb 27, 2023 - Mar 03, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Edmonton, Alberta--(Newsfile Corp. - November 30, 2022) - Radient Technologies Inc. (TSXV: RTI) ("Radient" or the "Company"), a commercial manufacturer of diverse, novel, and high-quality cannabis extracts and packaged products, reports its financial results for the quarter ended June 30, 2022. Recent key highlights:Received from Health Canada an amendment to the Company's Standard Processing License for the sale of dried and fresh cannabis and a sale for medical purposes licence, allowing the C
Edmonton, Alberta--(Newsfile Corp. - October 28, 2022) - Radient Technologies Inc. (TSXV: RTI) ("Radient" or the "Company"), a commercial manufacturer of diverse, novel and high-quality cannabis extracts and packaged products, announces the appointment of Dr. Steven Splinter as interim CEO, Dimitris Tzanis as director, and announces that the Company intends to complete a promissory note financing.Dr. Steven Splinter is appointed interim CEO of Radient effective October 28, 2022. Dr. Splinter is
Edmonton, Alberta--(Newsfile Corp. - October 21, 2022) - Radient Technologies Inc. (TSXV: RTI) ("Radient" or the "Company"), a commercial manufacturer of diverse, novel, and high-quality cannabis extracts and packaged products, reports its financial results for the quarter ended June 30, 2022.Recent key highlights:Acquired Tunaaaaroom Xtracts Inc. ("TRX"), for the development and sales of premium cannabis products, which are now sold through provincially licensed retailers;Partnered with All Goo